The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

被引:121
|
作者
Savant, Sudha S. [1 ]
Sriramkumar, Shruthi [2 ]
O'Hagan, Heather M. [1 ,3 ]
机构
[1] Indiana Univ Sch Med, Med Sci, Bloomington, IN 47405 USA
[2] Indiana Univ, Cell Mol & Canc Biol Grad Program, Bloomington, IN 47405 USA
[3] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA
关键词
inflammation; epithelial ovarian cancer; cytokines; reactive oxygen species; growth factors; ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANCHORAGE-INDEPENDENT GROWTH; FACTOR RECEPTOR EXPRESSION; INTERLEUKIN-6; SERUM-LEVELS; C-REACTIVE PROTEIN; NF-KAPPA-B; LYSOPHOSPHATIDIC ACID; CELL-PROLIFERATION;
D O I
10.3390/cancers10080251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC.
引用
收藏
页数:30
相关论文
共 50 条
  • [31] Inhibition of Inflammatory Mediators: Role of Statins in Airway Inflammation
    Wang, Weihua
    Le, Wei
    Ahuja, Rahul
    Cho, Do-Yeon
    Hwang, Peter H.
    Upadhyay, Daya
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2011, 144 (06) : 982 - 987
  • [32] Inflammatory mediators in the development and progression of benign prostatic hyperplasia
    De Nunzio, Cosimo
    Presicce, Fabrizio
    Tubaro, Andrea
    NATURE REVIEWS UROLOGY, 2016, 13 (10) : 613 - 626
  • [33] Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
    Lane, Denis
    Matte, Isabelle
    Garde-Granger, Perrine
    Laplante, Claude
    Carignan, Alex
    Rancourt, Claudine
    Piche, Alain
    BMC CANCER, 2015, 15
  • [34] Inflammation and Myeloid Cells in Cancer Progression and Metastasis
    Deng, Jenying
    Fleming, Jason B.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [35] HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer
    Wang, Yao
    Li, Mingxun
    Meng, Fanling
    Lou, Ge
    HUMAN PATHOLOGY, 2017, 60 : 114 - 120
  • [36] The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer
    Pudelko, Adam
    Wisowski, Grzegorz
    Olczyk, Krystyna
    Kozma, Ewa Maria
    FEBS JOURNAL, 2019, 286 (10) : 1815 - 1837
  • [37] Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma
    Dunn, Jeffrey H.
    Ellis, Lixia Z.
    Fujita, Mayumi
    CANCER LETTERS, 2012, 314 (01) : 24 - 33
  • [38] The Role of Inflammation in the Cardio-Renal Syndrome: A Focus on Cytokines and Inflammatory Mediators
    Rosner, Mitchell H.
    Ronco, Claudio
    Okusa, Mark D.
    SEMINARS IN NEPHROLOGY, 2012, 32 (01) : 70 - 78
  • [39] MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression
    Zhang, Jing
    Liu, Lei
    Sun, Yunyan
    Xiang, Jiandong
    Zhou, Dongmei
    Wang, Li
    Xu, Huali
    Yang, Xiaoming
    Du, Na
    Zhang, Meng
    Yan, Qin
    Xi, Xiaowei
    ONCOTARGET, 2016, 7 (18) : 26516 - 26534
  • [40] Strategies to overcome chemoresistance in epithelial ovarian cancer: Navigating beyond challenges
    Nguyen, Que Thanh Thanh
    Kim, Jihye
    Yoo, Hee Chan
    Lee, Eun-Ju
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 210